888葡京集团(CHN)检测线路-Baidu百科

XBioR™ Stainless Steel Bioreactor System for Humanized Antibody Production

Application Overview

The XBioR™ Stainless Steel Bioreactor System provides a highly stable, scalable, and cGMP-compliant platform dedicated to the suspension culture of mammalian cells for the industrial production of humanized antibodies. As monoclonal antibodies, bispecific antibodies, multispecific antibodies, and antibody-drug conjugates continue to dominate the biopharmaceutical market, the demand for robust, controllable, and high-yield cell culture processes has become increasingly critical. The XBioR™ system is engineered to support long-term, high-density cell culture with precise environmental control, low shear stress, and reliable sterility, making it suitable for both process development and large-scale commercial manufacturing.

By integrating advanced aeration modes, intelligent parameter control, and CFD-optimized internal structure, the bioreactor ensures uniform distribution of oxygen, nutrients, and metabolites throughout the culture cycle. This significantly improves cell viability, prolongs the stable culture period, and enhances the final antibody expression titer. The system effectively addresses common challenges in antibody production, including cell damage caused by excessive shear force, insufficient oxygen transfer, unstable process parameters, and risks of contamination during long-period culture.

Key Performance Advantages

The XBioR™ bioreactor features a low-shear impeller system that reduces mechanical damage to fragile mammalian cells while maintaining excellent mixing efficiency. Combined with a high-performance dissolved oxygen control strategy, it supports high-density cell growth and stable protein expression. The precise automatic control of pH, temperature, agitation, foam, and feeding ensures process repeatability and batch-to-batch consistency, which is essential for regulatory compliance and quality control.

Full-automatic SIP (Sterilization in Place) and CIP (Cleaning in Place) functions minimize manual intervention and effectively reduce the risk of microbial or viral contamination. The integrated dual-filter exhaust system with heating and cooling protection further enhances biosafety during long-term cultivation. The system supports multiple culture modes, including batch, fed-batch, and perfusion culture, allowing flexible process development for different cell lines and antibody products.

In addition, the XBioR™ system is compatible with PAT (Process Analytical Technology) tools such as off-gas analysis and Raman spectroscopy, enabling real-time monitoring of cell density, metabolic status, and nutrient consumption. This supports data-driven process optimization and accelerates the transfer from lab-scale research to clinical and commercial production.

Industry Application Value

For biopharmaceutical enterprises engaged in the development and production of humanized antibodies, the XBioR™ bioreactor system provides reliable performance that meets global regulatory standards including cGMP, ASME BPE, and ISA-88. Its modular design allows smooth scale-up from small-scale development to large-scale production, shortening the development cycle and reducing production costs.

With stable performance, high security, and strong scalability, the system has become a preferred choice for many biotech companies and CDMOs engaged in antibody drug development and production. It helps improve product quality, ensure production stability, and support the efficient launch of innovative antibody drugs to the market.